Clinical Trial Update: Effect of Milnacipran in Chronic Neuropathic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of milnacipran for chronic neuropathic low back pain has completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Neuropathic Pain

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Northwestern University | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-09-25